Roy Ovel has more than 30 years’ experience working in international business development at both small local CROs and leading global CROs including ICON, TFS and Worldwide Clinical Trials.

His experience spans the globe and the drug development continuum. As a leader with strong commercial acumen, his focus is on working with customers to meet their needs – crucial in an environment where demands on pharmaceutical and biotech customers continue to grow.

He is highly customer-focused, with an ability to develop high-performing teams whilst maintaining a holistic approach to business.